Calcium acetate acts mainly by binding to dietary phosphate and forming insoluble calcium phosphate, which reduces the absorption of phosphate from the gastrointestinal tract. This action is particularly useful in the management of hyperphosphatemia, especially in patients with chronic kidney disease (CKD), who typically have elevated phosphate levels due to their inability to excrete phosphate effectively.